Fenimore Asset Management’s AbbVie ABBV Stock Holding History

Fenimore Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Hold	7,425	–	–	0.04%	77
2026 Q1	$1.61M	Sell	7,425 -23	-0.3%	-$5.1K	0.04%	73
2025 Q4	$1.7M	Sell	7,448 -5	-0.1%	-$1.14K	0.04%	74
2025 Q3	$1.73M	Hold	7,453	–	–	0.03%	74
2025 Q2	$1.38M	Hold	7,453	–	–	0.03%	76
2025 Q1	$1.56M	Sell	7,453 -28	-0.4%	-$5.44K	0.03%	78
2024 Q4	$1.33M	Sell	7,481 -27	-0.4%	-$4.96K	0.03%	78
2024 Q3	$1.48M	Buy	7,508 +27	+0.4%	+$5.04K	0.03%	80
2024 Q2	$1.28M	Hold	7,481	–	–	0.03%	79
2024 Q1	$1.36M	Sell	7,481 -29	-0.4%	-$5K	0.03%	77
2023 Q4	$1.16M	Sell	7,510 -8	-0.1%	-$1.17K	0.03%	79
2023 Q3	$1.12M	Hold	7,518	–	–	0.03%	78
2023 Q2	$1.01M	Hold	7,518	–	–	0.03%	81
2023 Q1	$1.2M	Sell	7,518 -300	-4%	-$45.9K	0.03%	77
2022 Q4	$1.26M	Hold	7,818	–	–	0.03%	83
2022 Q3	$1.05M	Hold	7,818	–	–	0.03%	83
2022 Q2	$1.2M	Sell	7,818 -57	-0.7%	-$8.71K	0.03%	84
2022 Q1	$1.28M	Hold	7,875	–	–	0.03%	84
2021 Q4	$1.07M	Hold	7,875	–	–	0.02%	87
2021 Q3	$849K	Hold	7,875	–	–	0.02%	87
2021 Q2	$887K	Hold	7,875	–	–	0.02%	89
2021 Q1	$852K	Sell	7,875 -100	-1%	-$10.7K	0.02%	87
2020 Q4	$855K	Hold	7,975	–	–	0.02%	82
2020 Q3	$699K	Hold	7,975	–	–	0.02%	83
2020 Q2	$783K	Buy	+7,975	New	+$702K	0.03%	83

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fenimore Asset Management's ABBV Position: Q2 2026 in Review

Fenimore Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 7,425 shares worth $1.87M. The position accounts for 0.04% of the portfolio, ranked #77.

Fenimore Asset Management first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fenimore Asset Management held 7,425 shares of AbbVie worth $1.87M as of Q2 2026.
Fenimore Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of Fenimore Asset Management's portfolio in Q2 2026, its #77 holding.
Fenimore Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fenimore Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.